Directory
>
Peter Kang
Peter Kang
VP R&D Clinical Genomics | Natera
Los Altos, California, United States
Peter Kang
Summary
Peter Kang is a highly accomplished Genomic Pathologist with extensive experience in clinical genomics and molecular diagnostics. He currently serves as VP of R&D Clinical Genomics at Natera, where he leverages his expertise in bioinformatics and machine learning to drive innovation in genomic research. With board certifications in Clinical Pathology and Molecular Genetic Pathology, Peter has a robust academic background, including a Master's in Biomedical Informatics from Stanford University. His previous roles include Chief Medical Officer at Promis Diagnostics and Executive Medical Director at Counsyl, showcasing his leadership in the medical field. Peter has contributed to significant publications in genetics and informatics, reflecting his commitment to advancing medical knowledge. He is passionate about the intersection of technology and healthcare, particularly in improving diagnostic capabilities. Peter's diverse experience across startups and established organizations underscores his adaptability and strategic vision in the rapidly evolving field of genomics.
Peter Kang
Work Experience
VP R&D Clinical Genomics at
Natera
March 2024 - Present
VP Genomics R&D at
TEMPUS LABS LIMITED
March 2021 - December 2023
VP R&D, Clinical Genomics at
Natera
February 2020 - February 2021
Chief Medical Officer at
Promis Diagnostics
July 2019 - February 2020
Executive Medical Director at
Myriad Women's Health, Inc.
May 2016 - March 2019
Medical Director at
Myriad Women's Health, Inc.
April 2015 - May 2016
Laboratory Director at
Myriad Women's Health, Inc.
February 2012 - April 2015
Assistant Professor at
Roswell Park Comprehensive Cancer Center
August 2007 - July 2010
Peter Kang
Education
Stanford University School of Medicine, Ms
January 2010 - January 2012
University of Pittsburgh School of Medicine, Fellowship
January 2005 - January 2007
Washington University in St. Louis School of Medicine, Residency
January 2001 - January 2005
Seoul National University, M.D.
January 1994 - January 2000
Frequently Asked Questions about Peter Kang
What is Peter Kang email address?
Peter Kang's primary email address is **********@tempus.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Peter Kang work for?
Peter Kang is a VP R&D Clinical Genomics at Natera, a company specializing in Commercial physical research.
Where Peter Kang graduated from?
Peter Kang holds a degree in Biomedical Informatics from Stanford University School of Medicine.
How can I directly contact Peter Kang?
To contact Peter Kang directly, you can use the email address **********@tempus.com. Complete contact information is available upon registration with Muraena.
Who is Peter Kang?
Peter Kang is a highly accomplished Genomic Pathologist with extensive experience in clinical genomics and molecular diagnostics. He currently serves as VP of R&D Clinical Genomics at Natera, where he leverages his expertise in bioinformatics and machine learning to drive innovation in genomic research. With board certifications in Clinical Pathology and Molecular Genetic Pathology, Peter has a robust academic background, including a Master's in Biomedical Informatics from Stanford University. His previous roles include Chief Medical Officer at Promis Diagnostics and Executive Medical Director at Counsyl, showcasing his leadership in the medical field. Peter has contributed to significant publications in genetics and informatics, reflecting his commitment to advancing medical knowledge. He is passionate about the intersection of technology and healthcare, particularly in improving diagnostic capabilities. Peter's diverse experience across startups and established organizations underscores his adaptability and strategic vision in the rapidly evolving field of genomics.
Peter`s contact details
**********@tempus.com
******@stanford.edu
**********@counsyl.com
*****@natera.com
Colleagues
VP of finance
SVP of Sales
VP of Transactions, BD and Licensing
Vice President Research And Development, Oncology
Senior Vice President, R&D
Senior Vice President, General Counsel
Chief Financial Officer
Vice President, Organ Health Sales
Vice President of Commercial Operations
President, Clinical Diagnostics